The University HealthSystem Consortium (UHC), formed in 1984, is an alliance of 97 academic medical centers and 153 of their affiliated hospitals representing more than 90% of the nation's non-profit academic medical centers. UHC offers its members specific programs and services to improve clinical, operational and patient safety performance. The mission of the University HealthSystem Consortium is to advance knowledge, foster collaboration, and promote change to help members succeed in their respective markets.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other indications. The company applies its expertise in medical devices, pharmaceuticals, and biotechnology to make a meaningful difference in patients' lives.
This release includes forward-looking statements concerning
expectations related to the two-year extension of the current agreement
between Novation (on behalf of UHC) and Baxter, including those
expectations related to the sale of Baxter products including intravenous
(IV) solutions, drug delivery products, nutrition products, IV
administration sets and components and infusion pumps to members of UHC.
The statements are based on a
|SOURCE Baxter International Inc.|
Copyright©2007 PR Newswire.
All rights reserved